These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 19802919

  • 1. Renal and retinal effects of enalapril and losartan in type 1 diabetes.
    Katavetin P, Katavetin P.
    N Engl J Med; 2009 Oct 01; 361(14):1410-1; author reply 1411. PubMed ID: 19802919
    [No Abstract] [Full Text] [Related]

  • 2. Renal and retinal effects of enalapril and losartan in type 1 diabetes.
    Tamsma JT.
    N Engl J Med; 2009 Oct 01; 361(14):1410; author reply 1411. PubMed ID: 19797291
    [No Abstract] [Full Text] [Related]

  • 3. Diabetes complications and the renin-angiotensin system.
    Perkins BA, Aiello LP, Krolewski AS.
    N Engl J Med; 2009 Jul 02; 361(1):83-5. PubMed ID: 19571288
    [No Abstract] [Full Text] [Related]

  • 4. Renin angiotensin system (RAS) blockade and diabetic microvascular complications in the eye and kidney.
    Bilous R.
    Prim Care Diabetes; 2008 Dec 02; 2(4):201-2. PubMed ID: 18760685
    [No Abstract] [Full Text] [Related]

  • 5. Primary prevention using losartan in type 1 diabetic patients significantly reduces retinopathy.
    Cardiovasc J Afr; 2009 Dec 02; 20(4):265. PubMed ID: 19701543
    [No Abstract] [Full Text] [Related]

  • 6. Renal and retinal effects of enalapril and losartan in type 1 diabetes.
    Mauer M, Zinman B, Gardiner R, Suissa S, Sinaiko A, Strand T, Drummond K, Donnelly S, Goodyer P, Gubler MC, Klein R.
    N Engl J Med; 2009 Jul 02; 361(1):40-51. PubMed ID: 19571282
    [Abstract] [Full Text] [Related]

  • 7. Treating diabetic nephropathy: unfinished success is not failure.
    Lewis J.
    Clin J Am Soc Nephrol; 2007 May 02; 2(3):407-9. PubMed ID: 17699442
    [No Abstract] [Full Text] [Related]

  • 8. The relation of ambulatory blood pressure and pulse rate to retinopathy in type 1 diabetes mellitus: the renin-angiotensin system study.
    Klein R, Moss SE, Sinaiko AR, Zinman B, Gardiner R, Suissa S, Donnelly SM, Kramer MS, Goodyer P, Strand T, Mauer M.
    Ophthalmology; 2006 Dec 02; 113(12):2231-6. PubMed ID: 16996597
    [Abstract] [Full Text] [Related]

  • 9. Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review.
    Sjølie AK, Dodson P, Hobbs FR.
    Int J Clin Pract; 2011 Feb 02; 65(2):148-53. PubMed ID: 21235695
    [Abstract] [Full Text] [Related]

  • 10. The Renin-Angiotensin system and vascular disease in diabetes.
    Deinum J, Chaturvedi N.
    Semin Vasc Med; 2002 May 02; 2(2):149-56. PubMed ID: 16222606
    [Abstract] [Full Text] [Related]

  • 11. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB.
    Postgrad Med; 2009 Mar 02; 121(2):89-101. PubMed ID: 19332966
    [Abstract] [Full Text] [Related]

  • 12. Kidney disease in diabetology: lessons from 2008.
    Schernthaner G.
    Nephrol Dial Transplant; 2009 Feb 02; 24(2):396-9. PubMed ID: 19144896
    [No Abstract] [Full Text] [Related]

  • 13. Renoprotection by blocking the RAAS in diabetic nephropathy--fact or fiction?
    Rossing P, Parving HH, de Zeeuw D.
    Nephrol Dial Transplant; 2006 Sep 02; 21(9):2354-7; discussion 2357-8. PubMed ID: 16928724
    [No Abstract] [Full Text] [Related]

  • 14. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
    Hollenberg NK, Epstein M.
    Clin J Am Soc Nephrol; 2006 Sep 02; 1(5):1046-8. PubMed ID: 17699325
    [No Abstract] [Full Text] [Related]

  • 15. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB, Coffman TM.
    Semin Nephrol; 2007 Mar 02; 27(2):144-52. PubMed ID: 17418683
    [Abstract] [Full Text] [Related]

  • 16. Prospects for angiotensin receptor blockers in diabetic retinopathy.
    Sjølie AK.
    Diabetes Res Clin Pract; 2007 May 02; 76 Suppl 1():S31-9. PubMed ID: 17321627
    [Abstract] [Full Text] [Related]

  • 17. Renin-angiotensin blockade in diabetic retinopathy.
    Ghattas A, Lip PL, Lip GY.
    Int J Clin Pract; 2011 Feb 02; 65(2):113-6. PubMed ID: 21235693
    [No Abstract] [Full Text] [Related]

  • 18. Progression of renal disease--can we forget about inhibition of the renin-angiotensin system?
    Mann JF, McClellan WM, Kunz R, Ritz E.
    Nephrol Dial Transplant; 2006 Sep 02; 21(9):2348-51; discussion 2352-3. PubMed ID: 16822789
    [No Abstract] [Full Text] [Related]

  • 19. [RAS blockade in diabetic nephropathy. "Early intervention can dramatically decrease loss of function].
    Ritz E.
    MMW Fortschr Med; 2004 Sep 16; 146(38):12. PubMed ID: 15532423
    [No Abstract] [Full Text] [Related]

  • 20. Renin-Angiotensin system blockade for diabetic nephropathy prevention.
    Naviglio S, Pirozzi F.
    Am J Cardiol; 2010 May 15; 105(10):1505. PubMed ID: 20451706
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.